Prostavasin 20 micrograms powder for solution for infusion Bulgaria - búlgaro - Изпълнителна агенция по лекарствата

prostavasin 20 micrograms powder for solution for infusion

ucb pharma gmbh - Алпростадил - 20 micrograms powder for solution for infusion

Xyzal 5 mg film - coated tablets  Bulgaria - búlgaro - Изпълнителна агенция по лекарствата

xyzal 5 mg film - coated tablets 

ucb pharma gmbh - Левоцетиризин - 5 mg film - coated tablets 

Xyzal 5 mg/ml oral drops, solution Bulgaria - búlgaro - Изпълнителна агенция по лекарствата

xyzal 5 mg/ml oral drops, solution

ucb pharma gmbh - Левоцетиризин - 5 mg/ml oral drops, solution

Moex 7,5 mg film - coated tablets Bulgaria - búlgaro - Изпълнителна агенция по лекарствата

moex 7,5 mg film - coated tablets

ucb pharma gmbh - moexipril - 7,5 mg film - coated tablets

Moex 15 mg film - coated tablets Bulgaria - búlgaro - Изпълнителна агенция по лекарствата

moex 15 mg film - coated tablets

ucb pharma gmbh - moexipril хидрохлорид - 15 mg film - coated tablets

Zyrtec 10 mg film - coated tablets Bulgaria - búlgaro - Изпълнителна агенция по лекарствата

zyrtec 10 mg film - coated tablets

ucb pharma gmbh - Цетиризин - 10 mg film - coated tablets

Zyrtec 10 mg/ml oral drops, solution Bulgaria - búlgaro - Изпълнителна агенция по лекарствата

zyrtec 10 mg/ml oral drops, solution

ucb pharma gmbh - Цетиризин - 10 mg/ml oral drops, solution

Perlinganit Loesung  1 mg/ml solution for infusion Bulgaria - búlgaro - Изпълнителна агенция по лекарствата

perlinganit loesung  1 mg/ml solution for infusion

ucb pharma gmbh - Глицерил trinitrate - 1 mg/ml solution for infusion

Zyrtec - D 5 mg/120 mg prolonged - release tablets  Bulgaria - búlgaro - Изпълнителна агенция по лекарствата

zyrtec - d 5 mg/120 mg prolonged - release tablets 

ucb pharma gmbh - Цетиризин - 5 mg/120 mg prolonged - release tablets 

Fintepla Unión Europea - búlgaro - EMA (European Medicines Agency)

fintepla

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - Противоэпилептические средства, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.